Krüger, Clara
Lim, Shen-Yang
Buhrmann, Alissa
Fahrig, Fenja L.
Gabbert, Carolin
Bahr, Natascha
Madoev, Harutyun
Marras, Connie
Klein, Christine
Lohmann, Katja https://orcid.org/0000-0002-5121-1460
Funding for this research was provided by:
International Parkinson and Movement Disorder Society
Parkinson's Foundation (875333)
Article History
Received: 16 July 2024
Accepted: 9 January 2025
First Online: 17 February 2025
Competing interests
: The authors declare no competing interests. C.M. has received honoraria from the Parkinson’s Foundation. C.K. serves as a medical advisor to Centogene and Takeda and previously to Retromer Therapeutics and has received Speakers’ honoraria from Desitin and Bial. K.L. is an Associate Editor at npj Parkinson’s Disease. K.L. was not involved in the journal’s review of, or decisions related to, this manuscript.